Business Standard

Nifty Pharma index sees biggest jump in four months, shows data

The Nifty Pharma index finished at 12,750, up 3.1 per cent - most since May 20 and third biggest single-day gain of the year

equity market, stocks, share market
Premium

Even after the latest surge, the Nifty Pharma index is down 10.4% on a YTD even as the Nifty has gained 2.7%

Sundar Sethuraman Thiruvananthapuram
Pharma shares rallied on Tuesday as investors looked to prune exposure from pockets that have rallied and move money into the ones which have been laggards. 

The Nifty Pharma index finished at 12,750, up 3.1 per cent — most since May 20 and third biggest single-day gain of the year. By comparison, the Nifty50 index finished with 1.1 per cent gain. Barring two, all components of the 20-share index rallied, with Cipla and Lupin surging the most at 5.5 per cent and 4.7 per cent, respectively.

The pharma sector is seen as a defensive play. It tends to outperform the

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in